申请人:WARNER-LAMBERT COMPANY
公开号:EP1233018A2
公开(公告)日:2002-08-21
Matrix metalloproteinase inhibitors are tricyclicsulfonamides of the Formula I
or a pharmaceutically acceptable salt thereof,
wherein R1 and R2 include hydrogen, alkyl, and substituted alkyl; R3 is OH or NHOH; X is O or S(O)n; n is 0, 1, or 2; p is 0, 1, 2, or 3; --- is absent or a bond; and the sulfur atom bearing (O)q is bonded to the benzo ring at position a or position b.
基质金属蛋白酶抑制剂是公式I的三环磺酰胺或其药学上可接受的盐,其中R1和R2包括氢、烷基和取代烷基;R3为OH或NHOH;X为O或S(O)n;n为0、1或2;p为0、1、2或3;---不存在或为键;并且带有(O)q的硫原子与苯环上的位置a或位置b连接。